112 related articles for article (PubMed ID: 8052154)
1. The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity.
Medeiros-Neto G; Lima N; Perozim L; Pedrinola F; Wajchenberg BL
Metabolism; 1994 Aug; 43(8):969-73. PubMed ID: 8052154
[TBL] [Abstract][Full Text] [Related]
2. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
Csizmadi I; Brazeau P; Serri O
Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
[TBL] [Abstract][Full Text] [Related]
3. Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women.
Kars ME; Pijl H; Cohen AF; Frölich M; Schoemaker HC; Brandenburg HC; Meinders AE
Clin Endocrinol (Oxf); 1996 May; 44(5):541-6. PubMed ID: 8762730
[TBL] [Abstract][Full Text] [Related]
4. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine.
Argenio GF; Bernini GP; Sgró M; Vivaldi MS; Del Corso C; Santoni R; Franchi F
Metabolism; 1991 Jul; 40(7):724-7. PubMed ID: 1870427
[TBL] [Abstract][Full Text] [Related]
5. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
6. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
[TBL] [Abstract][Full Text] [Related]
7. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration.
Sartorio A; Spada A; Bochicchio D; Atterrato A; Morabito F; Faglia G
Neuroendocrinology; 1986; 44(4):470-4. PubMed ID: 3102991
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenfluramine on insulin/growth hormone ratio in obese subjects.
Altomonte L; Zoli A; Ghirlanda G; Manna R; Greco AV
Pharmacology; 1988; 36(2):106-11. PubMed ID: 3281173
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
[TBL] [Abstract][Full Text] [Related]
11. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing growth hormone deficiency: the value of short-term hypocaloric diet.
Maghnie M; Valtorta A; Moretta A; Larizza D; Preti P; Palladini G; Calcante S; Severi F
J Clin Endocrinol Metab; 1993 Nov; 77(5):1372-8. PubMed ID: 8077335
[TBL] [Abstract][Full Text] [Related]
14. Effect of dose and frequency of administration of a potent analog of human growth hormone-releasing factor on hormone secretion and growth in pigs.
Dubreuil P; Petitclerc D; Pelletier G; Gaudreau P; Farmer C; Mowles TF; Brazeau P
J Anim Sci; 1990 May; 68(5):1254-68. PubMed ID: 2114396
[TBL] [Abstract][Full Text] [Related]
15. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
[TBL] [Abstract][Full Text] [Related]
16. The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.
Drent ML; Adèr HJ; van der Veen EA
J Endocrinol Invest; 1995 Nov; 18(10):780-8. PubMed ID: 8787955
[TBL] [Abstract][Full Text] [Related]
17. Impaired growth hormone response to insulin-induced hypoglycaemia in obese patients: restoration blocked by ritanserin after fenfluramine administration.
Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Birindelli R; Luisi M; Franchi F
Clin Endocrinol (Oxf); 1990 Apr; 32(4):453-9. PubMed ID: 2112069
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
[TBL] [Abstract][Full Text] [Related]
19. Decreased pituitary growth hormone response to growth hormone-releasing factor in cafeteria-fed rats: dietary and obesity effects.
Renier G; Gaudreau P; Hajjad H; Deslauriers N; Houde-Nadeau M; Brazeau P
Neuroendocrinology; 1990 Sep; 52(3):284-90. PubMed ID: 2145525
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
Dickerman Z; Guyda H; Tannenbaum GS
J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
